Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis

BACKGROUND: Neoadjuvant radiotherapy has been shown to improve marginal negative resection and local control of Pancreatic Ductal Adenocarcinoma (PDAC). However, whether it improves overall survival (OS) in patients with non-metastatic PDAC remains controversial. Therefore, the purpose of this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Dan, Liu, Chongshun, Zhou, Yuan, Yan, Tingyu, Li, Chenglong, Yang, Qionghui, Xu, Yang, Zhao, Lilan, Pei, Qian, Tan, Fengbo, Güngör, Cenap, Li, Yuqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222314/
https://www.ncbi.nlm.nih.gov/pubmed/32404114
http://dx.doi.org/10.1186/s13014-020-01561-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222314/
https://www.ncbi.nlm.nih.gov/pubmed/32404114
http://dx.doi.org/10.1186/s13014-020-01561-z

Ejemplares similares